{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-007944","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2024-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.429938+00:00","generated_at":"2026-05-29T06:03:44.131871+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"VolitionRx raises up to $1.9M in registered direct offering with warrants for additional $2.7M","bullets":["Offering includes 445,648 Insider Shares at $0.5722 and 2,857,389 shares with warrants at $0.5722.","Form A warrants exercisable at $0.5722/share, Form B at $0.71525/share, both expire Dec 2029.","Gross proceeds upfront ~$1.9M; potential additional $2.7M if warrants fully exercised.","Proceeds for R&D, clinical studies, product commercialization, and working capital.","Insiders participate; no placement agent; closing expected on Dec 9, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-007944","json":"https://secwatch.observer/filing/0001477932-24-007944.json","markdown":"https://secwatch.observer/filing/0001477932-24-007944.md","text":"https://secwatch.observer/filing/0001477932-24-007944.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793224007944/0001477932-24-007944-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793224007944/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T06:03:44.131871+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}